BCI maker Science acquires retinal implant from Pixium Vision

A rendering of the Prima System’s features, now acquired by Science. [Image from Pixium Vision]Brain-computer interface developer Science Corporation announced today that it acquired the IP and related assets for the Pixium Vision Prima implant.

Neuralink co-founder Max Hodak founded Science, which unveiled its Science Eye brain-computer platform in 2022. The Science Eye is a visual prosthesis. It targets retinitis pigmentosa (RP) and dry age-related macular degeneration (AMD), two forms of serious blindness.

The company now owns the retinal implant technology developed by Pixium Vision as well. France-based Pixium Vision said last fall that it was looking for a potential buyer.

The Prima System, a photovoltaic substitute of photoreceptors, already has FDA breakthrough device designation. It provides simultaneous use of the central prosthetic and peripheral natural vision. The company designed the implant for patients with atrophic dry age-related mac…

Read more
  • April 25, 2024
  • 0

Neuralink co-founder unveils Science Eye sight restoration implant

The Science Eye. [Image from Science]Neuralink co-founder Max Hodak and the Science team unveiled the Science Eye, the company’s brain-computer platform.

Now the Science CEO, Hodak helped start Neuralink, Elon Musk’s venture into brain-computer interfaces (BCIs). He served as president there until 2021. He’s now working on a new brain-computer platform. Contrary to Neuralink and other companies’ platforms, this one doesn’t require an in-skull implant.

The Science Eye is a visual prosthesis. It targets retinitis pigmentosa (RP) and dry age-related macular degeneration (AMD), two forms of serious blindness. The combination device uses an optogenetic gene therapy targeted at the cells of the optic nerve. It combines that with an implanted, flexible thin-film, ultradense microLED display panel inserted directly over the retina.

Hodak, Yifan Kong, Alan Mardinly, Corey Wolin, Emma Zhou and the Science team authored a news release unv…

Read more
  • November 22, 2022
  • 0